ISIN | CH0435830622 |
---|---|
Valor Number | 43583062 |
Bloomberg Global ID | ZKBASCA SW |
Fund Name | ZugerKB Fonds - Aktien ESG Schweiz (CHF) A |
Fund Provider |
Zuger Kantonalbank AG, Zug
Baarerstrasse 37 6301 Zug Phone: +41 41 709 11 11 |
Fund Provider | Zuger Kantonalbank AG, Zug |
Representative in Switzerland | |
Distributor(s) | Zuger Kantonalbank, Zug |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel des Teilvermögens ZugerKB Fonds - Aktien Schweiz (CHF) besteht in einem langfristig möglichst hohen Anlageertrag in der Rechnungseinheit CHF. |
Peculiarities |
Current Price * | 151.15 CHF | 04.02.2025 |
---|---|---|
Previous Price * | 152.26 CHF | 03.02.2025 |
52 Week High * | 153.86 CHF | 30.01.2025 |
52 Week Low * | 133.20 CHF | 09.02.2024 |
NAV * | 151.15 CHF | 04.02.2025 |
Issue Price * | 151.15 CHF | 04.02.2025 |
Redemption Price * | 151.15 CHF | 04.02.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 207,518,791 | |
Unit/Share Assets *** | 132,078,198 | |
Trading Information SIX |
YTD Performance | +7.09% |
31.12.2024 - 04.02.2025
31.12.2024 04.02.2025 |
---|---|---|
1 month | +5.92% |
06.01.2025 - 04.02.2025
06.01.2025 04.02.2025 |
3 months | +5.38% |
04.11.2024 - 04.02.2025
04.11.2024 04.02.2025 |
6 months | +9.01% |
05.08.2024 - 04.02.2025
05.08.2024 04.02.2025 |
1 year | +13.11% |
05.02.2024 - 04.02.2025
05.02.2024 04.02.2025 |
2 years | +18.49% |
06.02.2023 - 04.02.2025
06.02.2023 04.02.2025 |
3 years | +7.85% |
04.02.2022 - 04.02.2025
04.02.2022 04.02.2025 |
5 years | +39.37% |
04.02.2020 - 04.02.2025
04.02.2020 04.02.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 10.41% | |
---|---|---|
UBS Group AG | 8.39% | |
Novartis AG Registered Shares | 8.14% | |
Nestle SA | 7.04% | |
Alcon Inc | 5.45% | |
Holcim Ltd | 5.37% | |
ABB Ltd | 4.90% | |
Sika AG | 4.38% | |
Lonza Group Ltd | 4.33% | |
Givaudan SA | 3.76% | |
Last data update | 31.10.2024 |
TER | 1.30% |
---|---|
TER date | 30.11.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.31% |
SRRI ***
|
|
SRRI date *** | 31.12.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** |
Sustainable Investment |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |